Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
Genomatix Software GmbH today announced that it has achieved GeneChip-compatible GeneChip® microarray platform and that it has joined Affymetrix GeneChip-compatible Applications Program, which provides customers with a broad spectrum of software solutions for biomedical research and development. As a GeneChip-compatible...Genomatix technology facilitates de novo identification of new renal disease associated genes
Previously unknown molecules and regulatory pathways in human glomerular diseases have been identified by a joint effort of the Medizinische Poliklinik, Munich, the University of Bristol´s Children´s Renal Unit, the German Cancer Research Center, sanofi-aventis, and Genomatix Software GmbH. In a joint publication in the Proceedings of the National Academy of Sciences of the United States o...MatBase -- A new transcription factor knowledge base released by Genomatix
Genomatix Software GmbH, a pioneer and leader in the analysis of eukaryotic transcriptional regulation, releases MatBase, a knowledge base of transcription factors (TF). It contains genomic TF binding sites and protein binding domains, related literature, more than 27.000 known TF ?gene interactions, experimentally verified complexes with other TFs (promoter modules), and weight matrix de...Application of Genomatix in silico methods reveals novel cancer associated genes
Genomatix Software GmbH, an in silico systems biology company with headquarter in Munich (Germany), released today that researcher in Dublin, Ireland and Boston, U.S.A. identified novel cancer associated genes, based on strategies and products developed and promoted by Genomatix. Experimental verification by siRNA knock-down and RT-PCR confirmed the in silico results. "I am delighted that...Genomatix Licensed By Bayer Healthcare
Genomatix is a microarray platform which is now licensed by Bayer HealthCare. It enables biologists and bio-informaticians to analyze chip raw data//. It employs the latest genomic annotation. It combines both literature and pathway mining in a single coherent system. ‘After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector....